[Tardive dyskinesia]

Minerva Med. 1985 Apr 14;76(16):797-802.
[Article in Italian]

Abstract

Neuroleptic drug treatment can produce tardive dyskinesia of which the incidence, risk factors, clinical characteristics and problems of differential diagnosis are described. Possible therapeutic approaches are then considered in the light of the hypothesis that the condition may derive from a physiopathological hypersensitivity of the dopamine receptors.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Chorea / diagnosis
  • Diagnosis, Differential
  • Dyskinesia, Drug-Induced / diagnosis
  • Dyskinesia, Drug-Induced / epidemiology
  • Dyskinesia, Drug-Induced / etiology*
  • Dyskinesia, Drug-Induced / prevention & control
  • Dystonia / diagnosis
  • Humans
  • Italy
  • Parkinson Disease / diagnosis
  • Receptors, Dopamine / drug effects
  • Risk
  • Sympatholytics / adverse effects
  • Tic Disorders / diagnosis

Substances

  • Antipsychotic Agents
  • Receptors, Dopamine
  • Sympatholytics